Related Experiment Video
Updated: Nov 7, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK/STAT signaling
Yiya Yang1, Yuting Lei1, Yumei Liang1
1Department of Nephrology and Laboratory of Kidney Disease, Changsha Clinical Research Center for Kidney DiseaseHunan Clinical Research Center for Chronic Kidney Disease, Hunan Provincial People's Hospital, Hunan Normal University, 61#, Jiefang West Road, Changsha, 410005, Hunan Province, People's Republic of China.
Aim:
High glucose (HG) induces the production of transforming growth factor (TGF)-β and reactive oxygen species, which further activates JAK/STAT signaling and promotes the synthesis of matrix proteins, contributes to the pathophysiological processes of diabetic nephropathy. This study aims to investigate the protection role of vitamin D (VD) in the kidney in high glucose condition.
Methods:
Rat glomerular mesangial cells were cultured in high glucose medium, with or without VD or VD receptor (VDR) siRNAs treatment. The levels of TGF-β and fibronectin were detected by qRT-PCR, immunoblotting and enzyme-linked immunosorbent assay (ELISA). The levels of phosphorylated JAK2, STAT1 and STAT3, and JAK/STAT signaling downstream genes were examined by immunoblotting and qRT-PCR.
Results:
In rat glomerular mesangial cells, VD treatment can repress the tyrosine phosphorylation of JAK2, STAT1 and STAT3. VD inhibited TGF-β and fibronectin expression which was rescued by vitamin d receptor (VDR) siRNA and STATs inhibitor perficitinib. The JAK/STAT signaling downstream protein coding genes including SOCS1, SOCS3 and type IV collagen were repressed by VD. Meanwhile, the expression of non-coding RNAs such as miR-181a, miR-181b, was repressed by VD, and the expression of miR-34a and Let-7b was upregulated by VD.
Conclusion:
Vitamin D (VD) treatment inhibits the function of HG on fibronectin production through regulating JAK/STAT pathway. These results provide direct evidences that VD protects glomerular mesangial cells from high glucose-induced injury through repressing JAK/STAT signaling, which has the potential for clinical DN treatment.
Insights
Vitamin D (VD) protects kidney cells from high glucose damage by inhibiting the JAK/STAT pathway. This suggests VD is a potential treatment for diabetic nephropathy by reducing fibronectin production.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- High glucose (HG) triggers TGF-β and ROS production, activating JAK/STAT signaling.
- This pathway promotes matrix protein synthesis, contributing to diabetic nephropathy (DN) pathogenesis.
- Investigating protective agents against HG-induced kidney injury is crucial.
Purpose of the Study:
- To investigate the protective role of vitamin D (VD) in kidney cells under high glucose conditions.
- To elucidate the molecular mechanisms underlying VD's potential renoprotective effects.
Main Methods:
- Rat glomerular mesangial cells were cultured in high glucose medium.
- Cells were treated with VD or vitamin D receptor (VDR) siRNAs.
- TGF-β, fibronectin, JAK/STAT pathway components, and downstream gene expression were analyzed using qRT-PCR, immunoblotting, and ELISA.
Main Results:
- VD treatment suppressed tyrosine phosphorylation of JAK2, STAT1, and STAT3.
- VD inhibited TGF-β and fibronectin expression, effects reversed by VDR siRNA and a STATs inhibitor.
- VD repressed JAK/STAT downstream genes (SOCS1, SOCS3, type IV collagen) and modulated specific microRNAs (miR-181a/b downregulated, miR-34a/Let-7b upregulated).
Conclusions:
- Vitamin D inhibits high glucose-induced fibronectin production via the JAK/STAT pathway.
- VD demonstrates renoprotective effects by repressing JAK/STAT signaling in glomerular mesangial cells.
- These findings support VD's potential as a therapeutic strategy for diabetic nephropathy.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
The JAK-STAT Signaling Pathway
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational
Insulin Secretory Vesicles
cAMP-dependent Protein Kinase Pathways